Tanita Corp. is a Japanese private company located in Tokyo that operates in several countries and manufactures commercial, pediatric, healthcare, mini, jewelry & fitness monitoring scales.

Sorin CRM SAS designs and manufactures implantable pacemakers and defibrillators. It offers ICDs, leads, holter equipment, and electrophysiology catheters. The company was founded on July 25, 1977 and is headquartered in Clamart, France.

Videregen’s goal is to offer the world’s first commercially available organ replacement products to address the chronic shortage of organs for transplantation. Formed in 2011 as a spin-out from Northwick Park Institute of Medical Research in London, it uses its proprietary technology to produce biological scaffolds to which a patient’s own stem cells are added, creating a bespoke organ replacement. Initially focused on diseases of the trachea and bowel, Videregen aims to develop the world’s first commercially available organ replacements for these conditions, reducing healthcare costs and improving the quality of life for patients.

Cannuflow is the recognized innovation leader in fluid management and access devices for arthroscopy and sports medicine procedures (knee shoulder and hip scopes) Cannuflow has 14 revenue-generating products and sells in over 8 countries. They are continuously innovating to improve surgical efficiency, eliminate preventable complications and lower costs in orthopedics, sports medicine, and other indications, and work with a worldwide network of clinical researchers at top institutions. They have a track record of generating industry leading innovations backed by strong IP that are clinically accepted with clinical and health economics data with exceptional capital efficiency. The funding and valuation below are for expansion capital to grow the Cannuflow cannula business revenues and product development.

Cytyc Corporation, a diagnostic and medical device company, designs, develops, manufactures, and markets and diagnostic and surgical products. The company offers its products for a range of cancer and women's health applications, such as cervical cancer screening, menstrual bleeding treatment, early-stage breast cancer radiation treatment, and malignant brain tumors radiation treatment applications. It serves customers in the Canadian, European, and Asia/Pacific markets. The company was founded in 1987 and is based in Marlborough, Massachusetts. As of October 22, 2007, CYTYC Corporation opeartes as a subsidiary of Hologic Inc.

Novacept was founded in 1995 to design, develop, manufacture and market innovative therapeutic devices to improve the quality of women's healthcare in a cost-effective manner. Developed by Novacept, the NovaSure Impedance Controlled Endometrial Ablation System is a next generation medical device designed to reduce or eliminate excessive menstrual bleeding due to benign causes in pre-menopausal women who have completed childbearing.

RaQualia began operations in July 2008 with a corporate mission, "They seek to bring people health and happiness through innovative new medications." Thanks to the support of all of their stakeholders, the company was listed on the JASDAQ Growth Market in July 2011. They have transformed RaQualia's R&D strategy, which is now based on the concept of "selection and concentration." They are now focusing on their core competencies in targeting ion channels in the fields of pain and gastrointestinal disease. In addition, they have made a strategic decision to relocate RaQualia's discovery processes to Nagoya University to better promote synergy effects with academia. With the Chubu region as their base, they are continuing with further efforts enhance their capabilities in drug discovery, improve shareholder value, and achieve financial stability by promoting licensing activities and alliance management with their corporate partners. They will continue to work tirelessly in providing patients with innovative medicines sooner by increasing the pace of drug development. Thank you very much for your continued support of RaQualia.

SanguiBioTech GmbH, a subsidiary of Sangui BioTech International, Inc., is a company headquartered in Germany that engages in the research, development, manufacture, and sales of medical and cosmetic products. Hubertus Schmelz is the current CEO, occupying that position since 2003.

Pristine Surgical LLC is an American company located in Manchester, NH, that develops and operates software platform for digital imaging. It was founded by Bryan Lord, he is currently the CEO of the firm.\nThe company says this about itself: Pristine Surgical has developed a first-of-its-kind, single-use visualization platform for surgical and diagnostic rigid endoscopic procedures by combining state-of-the-art, high-definition digital imaging with advanced LED lighting, artificial intelligence and cloud-based software. Its single-use arthroscopes and laparoscopes are delivered in a 100% sterile kit, and together with its cloud-based workflow reduction software, promises to reduce cost, reduce risk and increase efficiency for over 23 million procedures per year. Headquartered in Manchester, New Hampshire in the greater Boston medical device cluster, Pristine is led by an experienced management team, a seven-person board of directors and a ten-person medical advisory board.

Terumo Cardiovascular provides perfusion products, endoscopic vessel harvesting products, and surgical stabilization products. They provide medical devices and services for the benefit of patients and medical settings in more than 160 countries.

Physical Sciences provides contract research and development services in a wide diversity of technical areas to both government and commercial users. It offers adaptive infrared imaging spectroradiometers, compact adaptive optics retinal imagers, CR-doped ZNSE crystals, GASSCAN miniature diode laser-based ambient gas sensors, hand-held line scanning laser ophthalmoscopes, hybrid LSLO/spectral domain OCT imagers, lyoflux mass flux monitors, orientation-patterned gallium arsenide frequency converter devices, pharmaceutical process analytical technology sensors, quantum cascade laser sensors, RMLD portable standoff hazardous gas detectors, sideview microplates, tracking scanning laser ophthalmoscopes, tracking optical coherence tomography imagers, multi-wavelength gas sensors, tunable diode laser gas sensors, water vapor dials, and more. Physical Sciences Inc. was founded in 1973 and is headquartered in Andover, Massachusetts.

The Group's principal activity is to produce pharmaceuticals and chemicals. The operations are carried out through the following divisions: Pharmaceuticals; Bio chemical; Chemicals; Food and Other. Pharmaceuticals include ethical drugs, bulk pharmaceuticals and biological research. Bio chemicals deal with biochemical diagnostic reagents, animal health products, agrochemicals and fertilizers. Chemicals includes solvents, plasticizes and their raw materials, detergent raw materials and specialty chemicals. Food includes alcoholic beverages, alcohol, seasonings, confectionery, baking ingredients and processed foods. Others include wholesale, commodity distribution and installation of facilities.

Toray Industries, Inc. (東レ株式会社 Tōre Kabushiki-gaisha) is a multinational corporation headquartered in Japan that specializes in industrial products centered on technologies in organic synthetic chemistry, polymer chemistry, and biochemistry.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

Lunan Pharmaceutical Group is an Integrated pharmaceutical group, National innovative enterprise and National torch plan key high-tech enterprise that produces, researches and sells both traditional Chinese medicine, chemical medicine and bio-pharmaceutical medicinal products.

Massachusetts General Hospital was established to provide care to Boston's sick, regardless of socioeconomic status—an innovative idea in 1811. In the words of their founder, John Warren, MD, “When in distress, every man becomes their neighbor.” They subsequently became the first teaching hospital for Harvard University’s new medical school and have been redefining excellence in healthcare ever since. They have remained at the forefront of medicine by fostering a culture of collaboration, pushing the boundaries of medical research, educating the brightest medical minds and maintaining an unwavering commitment to the diverse community they were created to serve. They believe that because of diversity they excel, through inclusion they respect their community, and with a keen focus on equity they serve, heal, educate and innovate at the highest levels. Their first priority is the well-being of their patients—near and far. As a team they are able to maintain a singular focus on providing the highest quality, most compassionate care to each and every patient.